- Previous Close
3.7500 - Open
3.7500 - Bid 3.1700 x 100
- Ask 3.3600 x 100
- Day's Range
3.0900 - 3.8101 - 52 Week Range
2.6200 - 36.5200 - Volume
40,686 - Avg. Volume
31,052 - Market Cap (intraday)
337.909M - Beta (5Y Monthly) 0.38
- PE Ratio (TTM)
6.19 - EPS (TTM)
0.5300 - Earnings Date Jun 17, 2025 - Jun 21, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
10.00
SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.
sbc-holdings.com863
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SBC
View MorePerformance Overview: SBC
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SBC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SBC
View MoreValuation Measures
Market Cap
337.91M
Enterprise Value
228.79M
Trailing P/E
6.21
Forward P/E
4.75
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.51
Price/Book (mrq)
1.65
Enterprise Value/Revenue
1.02
Enterprise Value/EBITDA
2.37
Financial Highlights
Profitability and Income Statement
Profit Margin
22.69%
Return on Assets (ttm)
20.33%
Return on Equity (ttm)
27.56%
Revenue (ttm)
205.42M
Net Income Avi to Common (ttm)
46.61M
Diluted EPS (ttm)
0.5300
Balance Sheet and Cash Flow
Total Cash (mrq)
125.04M
Total Debt/Equity (mrq)
6.26%
Levered Free Cash Flow (ttm)
41.91M